Creatine and guanidinoacetate reference values in a French population (Q39340032)

11 September 2017

title

Creatine and guanidinoacetate reference values in a French population (English)

1 reference

11 September 2017

Richard Delorme

0 references

Karine Mention-Mulliez

Karine Mention-Mulliez

1 reference

11 September 2017

Vassili Valayannopoulos

Vassili Valayannopoulos

1 reference

Marie Joncquel-Chevalier Curt

11 September 2017

Marie Joncquel-Chevalier Curt

1 reference

11 September 2017

Jean-François Benoist

Jean-François Benoist

0 references

Delphine Héron

1 reference

11 September 2017

Alexandra Afenjar

1 reference

11 September 2017

Vincent Des Portes

1 reference

11 September 2017

François Cartault

1 reference

11 September 2017

David Cheillan

1 reference

11 September 2017

Gilbert Briand

1 reference

11 September 2017

Gajja S Salomons

1 reference

11 September 2017

Dries Dobbelaere

1 reference

11 September 2017

Jean-Marie Cuisset

1 reference

11 September 2017

Laurence Lion-François

1 reference

11 September 2017

Allel Chabli

1 reference

11 September 2017

Jean-Marc Pinard

1 reference

11 September 2017

Gilles Simard

1 reference

11 September 2017

Olivier Douay

1 reference

11 September 2017

Kumaran Deiva

1 reference

11 September 2017

Marc Tardieu

1 reference

11 September 2017

François Rivier

1 reference

11 September 2017

Brigitte Chabrol

1 reference

11 September 2017

Fabienne Prieur

1 reference

11 September 2017

Gaëlle Pitelet

1 reference

11 September 2017

Alice Goldenberg

1 reference

11 September 2017

Soumeya Bekri

1 reference

11 September 2017

Marion Gerard

1 reference

11 September 2017

Nicole Porchet

1 reference

11 September 2017

Christine Vianey-Saban

1 reference

11 September 2017

Joseph Vamecq

1 reference

11 September 2017

publication date

16 September 2013

1 reference

Molecular Genetics and Metabolism

11 September 2017

published in

1 reference

11 September 2017

volume

110

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

263-267

1 reference

Creatine in humans with special reference to creatine supplementation

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Creatine and creatinine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Myosine and Adenosinetriphosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Functions and effects of creatine in the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Synthesis and transport of creatine in the CNS: importance for cerebral functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Detection of low-level somatic and germline mosaicism by denaturing high-performance liquid chromatography in a EURO-MRX family with SLC6A8 deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

High frequency of creatine deficiency syndromes in patients with unexplained mental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Disorders of creatine transport and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Prevalence of the fragile X syndrome among Estonian mentally retarded and the entire children's population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

High prevalence of SLC6A8 deficiency in X-linked mental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Determination of guanidinoacetate and creatine in urine and plasma by liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring: Inter-laboratory comparison in urine with Jaffé, HPLC and enzymatic assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Methods for the diagnosis of creatine deficiency syndromes: A comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

GC‐MS determination of guanidinoacetate in urine and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

GC/MS determination of guanidinoacetate and creatine in urine: A routine method for creatine deficiency syndrome diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

An accurate stable isotope dilution gas chromatographic-mass spectrometric approach to the diagnosis of guanidinoacetate methyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Laboratory diagnosis of defects of creatine biosynthesis and transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Influence of sex hormones on amidinotransferase levels. Metabolic control of creatine biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Gender differences in serum and glucocorticoid regulated kinase-1 (SGK-1) expression during renal ischemia/reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1 and SGK3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

Seaweed intake and urinary sex hormone levels in preschool Japanese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.09.005

The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation

7 January 2021

1 reference

9 November 2024

https://opencitations.net/index/api/v1/citations/10.1007/S10545-008-1063-Y

Identifiers

DOI

10.1016/J.YMGME.2013.09.005

1 reference

11 September 2017

1 reference